Studies show alarming rates of fatty liver disease in young Indians, prompting calls for lifestyle changes and early ...

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

MASLD, previously called ‘fatty liver disease’, is a ticking timebomb, affecting 30 to 40 per cent of adults – most of whom ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Eating a diet high in red and processed meats puts you at greater risk for non-alcoholic fatty liver disease. These foods are ...

One in five individuals in India suffers from liver disease, according to renowned Epidemiologist Dr Naresh Purohit.

Learn how nonalcoholic fatty liver disease develops, its warning signs, and the steps to help safeguard the liver.

A meta-analysis of recent studies found a global steatotic liver disease prevalence of 37.5%. ( Clinical Gastroenterology and ...

Emerging research reveals a surprising link between gum disease and liver conditions like cirrhosis and MASLD.

Medications and procedures to treat cirrhosis symptoms include ... can be fatal if it progresses to liver failure. There are two clinical stages of cirrhosis: compensated and decompensated ...

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

Discover a study that ssessed the potential of urinary biomarkers to predict patient mortality in cirrhotic individuals.